These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

692 related items for PubMed ID: 25240403

  • 1. Arginine deiminase augments the chemosensitivity of argininosuccinate synthetase-deficient pancreatic cancer cells to gemcitabine via inhibition of NF-κB signaling.
    Liu J, Ma J, Wu Z, Li W, Zhang D, Han L, Wang F, Reindl KM, Wu E, Ma Q.
    BMC Cancer; 2014 Sep 20; 14():686. PubMed ID: 25240403
    [Abstract] [Full Text] [Related]

  • 2. Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase.
    Bowles TL, Kim R, Galante J, Parsons CM, Virudachalam S, Kung HJ, Bold RJ.
    Int J Cancer; 2008 Oct 15; 123(8):1950-5. PubMed ID: 18661517
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of AKT2 enhances sensitivity to gemcitabine via regulating PUMA and NF-κB signaling pathway in human pancreatic ductal adenocarcinoma.
    Chen D, Niu M, Jiao X, Zhang K, Liang J, Zhang D.
    Int J Mol Sci; 2012 Oct 15; 13(1):1186-1208. PubMed ID: 22312312
    [Abstract] [Full Text] [Related]

  • 4. Escin augments the efficacy of gemcitabine through down-regulation of nuclear factor-κB and nuclear factor-κB-regulated gene products in pancreatic cancer both in vitro and in vivo.
    Wang YW, Wang SJ, Zhou YN, Pan SH, Sun B.
    J Cancer Res Clin Oncol; 2012 May 15; 138(5):785-97. PubMed ID: 22270965
    [Abstract] [Full Text] [Related]

  • 5. Low‑intensity low‑frequency ultrasound enhances the chemosensitivity of gemcitabine‑resistant ASPC‑1 cells via PI3K/AKT/NF‑κB pathway‑mediated ABC transporters.
    Qiu F, Chen J, Cao J, Diao F, Huang P.
    Oncol Rep; 2020 Sep 15; 44(3):1158-1168. PubMed ID: 32705228
    [Abstract] [Full Text] [Related]

  • 6. Ursolic acid inhibits growth and induces apoptosis in gemcitabine-resistant human pancreatic cancer via the JNK and PI3K/Akt/NF-κB pathways.
    Li J, Liang X, Yang X.
    Oncol Rep; 2012 Aug 15; 28(2):501-10. PubMed ID: 22641480
    [Abstract] [Full Text] [Related]

  • 7. Modulation of pancreatic cancer chemoresistance by inhibition of TAK1.
    Melisi D, Xia Q, Paradiso G, Ling J, Moccia T, Carbone C, Budillon A, Abbruzzese JL, Chiao PJ.
    J Natl Cancer Inst; 2011 Aug 03; 103(15):1190-204. PubMed ID: 21743023
    [Abstract] [Full Text] [Related]

  • 8. Antitumor activity of gemcitabine can be potentiated in pancreatic cancer through modulation of TLR4/NF-κB signaling by 6-shogaol.
    Zhou L, Qi L, Jiang L, Zhou P, Ma J, Xu X, Li P.
    AAPS J; 2014 Mar 03; 16(2):246-57. PubMed ID: 24424498
    [Abstract] [Full Text] [Related]

  • 9. Melatonin overcomes gemcitabine resistance in pancreatic ductal adenocarcinoma by abrogating nuclear factor-κB activation.
    Ju HQ, Li H, Tian T, Lu YX, Bai L, Chen LZ, Sheng H, Mo HY, Zeng JB, Deng W, Chiao PJ, Xu RH.
    J Pineal Res; 2016 Jan 03; 60(1):27-38. PubMed ID: 26445000
    [Abstract] [Full Text] [Related]

  • 10. BRM/SMARCA2 promotes the proliferation and chemoresistance of pancreatic cancer cells by targeting JAK2/STAT3 signaling.
    Zhang Z, Wang F, Du C, Guo H, Ma L, Liu X, Kornmann M, Tian X, Yang Y.
    Cancer Lett; 2017 Aug 28; 402():213-224. PubMed ID: 28602977
    [Abstract] [Full Text] [Related]

  • 11. Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer.
    Banerjee S, Zhang Y, Ali S, Bhuiyan M, Wang Z, Chiao PJ, Philip PA, Abbruzzese J, Sarkar FH.
    Cancer Res; 2005 Oct 01; 65(19):9064-72. PubMed ID: 16204081
    [Abstract] [Full Text] [Related]

  • 12. [Role of nuclear factor-kappaB on emodin-induced sensitization of pancreatic cancer to gemcitabine].
    Liu A, Hu YS, Wang ZH, Tang LL, Ke PY, Lin SZ.
    Yao Xue Xue Bao; 2011 Feb 01; 46(2):146-52. PubMed ID: 21542284
    [Abstract] [Full Text] [Related]

  • 13. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products.
    Kunnumakkara AB, Guha S, Krishnan S, Diagaradjane P, Gelovani J, Aggarwal BB.
    Cancer Res; 2007 Apr 15; 67(8):3853-61. PubMed ID: 17440100
    [Abstract] [Full Text] [Related]

  • 14. Gemcitabine treatment promotes pancreatic cancer stemness through the Nox/ROS/NF-κB/STAT3 signaling cascade.
    Zhang Z, Duan Q, Zhao H, Liu T, Wu H, Shen Q, Wang C, Yin T.
    Cancer Lett; 2016 Nov 01; 382(1):53-63. PubMed ID: 27576197
    [Abstract] [Full Text] [Related]

  • 15. ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells.
    Liu M, Zhang Y, Yang J, Cui X, Zhou Z, Zhan H, Ding K, Tian X, Yang Z, Fung KA, Edil BH, Postier RG, Bronze MS, Fernandez-Zapico ME, Stemmler MP, Brabletz T, Li YP, Houchen CW, Li M.
    Gastroenterology; 2020 Feb 01; 158(3):679-692.e1. PubMed ID: 31711924
    [Abstract] [Full Text] [Related]

  • 16. Emodin potentiates the antitumor effects of gemcitabine in PANC-1 pancreatic cancer xenograft model in vivo via inhibition of inhibitors of apoptosis.
    Guo HC, Bu HQ, Luo J, Wei WT, Liu DL, Chen H, Tong HF, Wang ZH, Wu HY, Li HH, Zuo MM, Li W, Lin SZ.
    Int J Oncol; 2012 Jun 01; 40(6):1849-57. PubMed ID: 22378302
    [Abstract] [Full Text] [Related]

  • 17. [An experimental study of gemcitabine inducing pancreatic cancer cell apoptosis potentiated by nuclear factor-kappa B P65 siRNA].
    Kong R, Sun B, Wang SJ, Pan SH, Wang G, Chen H, Xue DB, Jiang HC.
    Zhonghua Wai Ke Za Zhi; 2010 Jan 15; 48(2):128-33. PubMed ID: 20302733
    [Abstract] [Full Text] [Related]

  • 18. Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer.
    Nagathihalli NS, Castellanos JA, Shi C, Beesetty Y, Reyzer ML, Caprioli R, Chen X, Walsh AJ, Skala MC, Moses HL, Merchant NB.
    Gastroenterology; 2015 Dec 15; 149(7):1932-1943.e9. PubMed ID: 26255562
    [Abstract] [Full Text] [Related]

  • 19. STAT1-mediated inhibition of FOXM1 enhances gemcitabine sensitivity in pancreatic cancer.
    Liu C, Shi J, Li Q, Li Z, Lou C, Zhao Q, Zhu Y, Zhan F, Lian J, Wang B, Guan X, Fang L, Li Z, Wang Y, Zhou B, Yao Y, Zhang Y.
    Clin Sci (Lond); 2019 Mar 15; 133(5):645-663. PubMed ID: 30782607
    [Abstract] [Full Text] [Related]

  • 20. Piperlongumine Suppresses Growth and Sensitizes Pancreatic Tumors to Gemcitabine in a Xenograft Mouse Model by Modulating the NF-kappa B Pathway.
    Wang Y, Wu X, Zhou Y, Jiang H, Pan S, Sun B.
    Cancer Prev Res (Phila); 2016 Mar 15; 9(3):234-44. PubMed ID: 26667450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.